The Ossian team specializes in creating bespoke computer simulation models for health economic evaluation and reimbursement. Our modeling knowledge is allied to world-leading expertise in value communications, which means that Ossian is uniquely placed to effectively demonstrate and communicate the value of your product throughout its lifecycle.
Early Product Development
Ossian can provide insight into early product value assessment, methodological and strategic advice, value development plans and strategies, and literature review support to inform health economic strategy and product positioning.
Pre-Launch
We have extensive experience of developing global value dossiers, pre-launch value development plans and strategies, cost-effectiveness and budget impact scenario modeling to inform pricing strategy, review and development of health economic evidence generation plans, review of existing economic models and health technology assessment (HTA) materials, critical review of HTA submissions, and integrated strategic support for reimbursement and HTA activities.
Launch & Post-Launch
Ossian specializes in the development of bespoke health economic models and economic evaluation to support reimbursement applications. We also offer considerable expertise in the preparation of global value dossiers and reimbursement submissions, demonstration of product value (e.g. multi-country cost-effectiveness analysis) and value communications.
Communicating Value
EFFECTIVELY COMMUNICATING VALUE
Ossian offers over 20 years of experience in value communications. We offer a wide range of tailored communications solutions from internal communication materials, value dossiers and training courses through to post-launch value development plans, strategies and tools to support mature products.
GLOBAL VALUE DOSSIERS & REGULATORY SUBMISSIONS
We specialize in the preparation of global value dossiers, HTA submissions and reports for regulatory submissions to support market access activities (including direct liaison with reimbursement authorities and/or HTA bodies) for both medical devices and pharmaceuticals in a number of countries.
PUBLICATIONS
Our team provides extensive experience in the development of publications plans and preparation of manuscripts for publication in peer-reviewed journals, congress materials (abstracts, posters, slide sets) and value messaging tools for effective communication to a broad range of stakeholders. Please see our publications list for more information.
Cost-effectiveness Analysis
Cost-effectiveness Analysis
The Ossian team specializes in the development of cost-effectiveness models to support pharmaceutical interventions and medical devices, and has long-standing experience in a range of modeling packages and therapy areas. We create models for early strategic planning through to reimbursement applications and post-launch value demonstration using a range of techniques and rigorous approaches, including the development of decision analytic models, cohort models and patient-level simulations, Markov models, probabilistic and deterministic methodologies, acceptability curves, and net health / net monetary benefit analyses.
Ossian also provides model review and critique services to our clients for models developed by third-parties and/or health technology assessment agencies.
Budget Impact Analysis
Budget Impact Analysis
Ossian has developed an innovative online framework to facilitate the rapid creation of budget impact analyses.
The framework provides an easy-to-use interface that guides users through the stages of building a budget impact model, defining the target population, competing products, market share predictions and cost offsets.
Literature Review
Literature Review
Literature review to identify strategically important evidence is a key tool to inform effective product positioning and demonstrate product value. The Ossian team has extensive experience in both systematic and targeted literature review, applying rigorous approaches across a range of literature search methodologies. This includes literature reviews to support market access applications and health economic analyses, burden of illness and unmet need evaluations, clinical and economic evidence summaries, therapeutic landscape reviews and gap analysis. Our goal is always to provide valuable strategic input for our clients by performing methodical, transparent and reproducible literature reviews that comply with health technology assessment agency and/or best practice guidance.